229 related articles for article (PubMed ID: 26025995)
1. A three-year study of a first-generation chemotherapy-compounding robot.
Nurgat Z; Faris D; Mominah M; Vibar A; Al-Jazairi A; Ewing S; Ashour M; Qaisi SK; Balhareth S; Al-Jedai A
Am J Health Syst Pharm; 2015 Jun; 72(12):1036-45. PubMed ID: 26025995
[TBL] [Abstract][Full Text] [Related]
2. Implementation of an i.v.-compounding robot in a hospital-based cancer center pharmacy.
Yaniv AW; Knoer SJ
Am J Health Syst Pharm; 2013 Nov; 70(22):2030-7. PubMed ID: 24173011
[TBL] [Abstract][Full Text] [Related]
3. [Implementation of a robot for the preparation of antineoplastic drugs in the Pharmacy Service].
Pacheco Ramos Mde L; Arenaza Peña AE; Santiago Pérez A; Bilbao Gómez-Martino C; Zamora Barrios MD; Arias Fernández ML
Farm Hosp; 2015 May; 39(3):137-46. PubMed ID: 26005888
[TBL] [Abstract][Full Text] [Related]
4. Automated compounding technology and workflow solutions for the preparation of chemotherapy: a systematic review.
Batson S; Mitchell SA; Lau D; Canobbio M; de Goede A; Singh I; Loesch U
Eur J Hosp Pharm; 2020 Nov; 27(6):330-336. PubMed ID: 33097615
[TBL] [Abstract][Full Text] [Related]
5. Single Center Experience with Robot Technologies for Sterile Compounding: A Retrospective Review.
Milibari L; Cotugno M; Belisle C; Rocchio M; Patterson RF; Chacon P; Fanikos J; Vo P
Int J Pharm Compd; 2020; 24(4):346-351. PubMed ID: 32649308
[TBL] [Abstract][Full Text] [Related]
6. Implementation and evaluation of a sterile compounding robot in a satellite oncology pharmacy.
Bhakta SB; Colavecchia AC; Coffey W; Curlee DR; Garey KW
Am J Health Syst Pharm; 2018 Jun; 75(11 Supplement 2):S51-S57. PubMed ID: 29802179
[TBL] [Abstract][Full Text] [Related]
7. Qualification of a chemotherapy-compounding robot.
Jobard M; Brandely-Piat ML; Chast F; Batista R
J Oncol Pharm Pract; 2020 Mar; 26(2):312-324. PubMed ID: 30997871
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of real-time data obtained from gravimetric preparation of antineoplastic agents shows medication errors with possible critical therapeutic impact: Results of a large-scale, multicentre, multinational, retrospective study.
Terkola R; Czejka M; Bérubé J
J Clin Pharm Ther; 2017 Aug; 42(4):446-453. PubMed ID: 28429389
[TBL] [Abstract][Full Text] [Related]
9. Robotic compounding versus manual compounding of chemotherapy: Comparing dosing accuracy and precision.
Geersing TH; Klous MG; Franssen EJF; van den Heuvel JJG; Crul M
Eur J Pharm Sci; 2020 Dec; 155():105536. PubMed ID: 32877721
[TBL] [Abstract][Full Text] [Related]
10. Microbiological performance of a robotic system for aseptic compounding of cytostatic drugs.
Geersing TH; Franssen EJF; Pilesi F; Crul M
Eur J Pharm Sci; 2019 Mar; 130():181-185. PubMed ID: 30710619
[TBL] [Abstract][Full Text] [Related]
11. Robotic i.v. medication compounding: Recommendations from the international community of APOTECAchemo users.
Yaniv AW; Orsborn A; Bonkowski JJ; Chew L; Krämer I; Calabrese S; de la Paz Pacheco Ramos M; Palombi A; Lim SW; Tabbara O; Masini C; Schierl R; Bufarini C; Peaty N; Paolucci D
Am J Health Syst Pharm; 2017 Jan; 74(1):e40-e46. PubMed ID: 28007720
[TBL] [Abstract][Full Text] [Related]
12. Sterile product compounding using an i.v. compounding workflow management system at a pediatric hospital.
Moniz TT; Chu S; Tom C; Lutz P; Arnold A; Gura KM; Patterson A
Am J Health Syst Pharm; 2014 Aug; 71(15):1311-7. PubMed ID: 25027539
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for i.v. compounding errors when using an automated workflow management system.
Deng Y; Lin AC; Hingl J; Huang G; Altaye M; Maynard H; Mayhaus D; Penm J
Am J Health Syst Pharm; 2016 Jun; 73(12):887-93. PubMed ID: 27261239
[TBL] [Abstract][Full Text] [Related]
14. Implementation and evaluation of a gravimetric i.v. workflow software system in an oncology ambulatory care pharmacy.
Reece KM; Lozano MA; Roux R; Spivey SM
Am J Health Syst Pharm; 2016 Feb; 73(3):165-73. PubMed ID: 26796911
[TBL] [Abstract][Full Text] [Related]
15. Assessment of an automatic robotic arm for dispensing of chemotherapy in a 2500-bed medical center.
Chen WH; Shen LJ; Guan RJ; Wu FL
J Formos Med Assoc; 2013 Apr; 112(4):193-200. PubMed ID: 23537865
[TBL] [Abstract][Full Text] [Related]
16. The assessment of environmental and external cross-contamination in preparing ready-to-administer cytotoxic drugs: a comparison between a robotic system and conventional manual production.
Werumeus Buning A; Geersing TH; Crul M
Int J Pharm Pract; 2020 Feb; 28(1):66-74. PubMed ID: 31489970
[TBL] [Abstract][Full Text] [Related]
17. Increasing pharmacy productivity and reducing medication turnaround times in an Italian comprehensive cancer center by implementing robotic chemotherapy drugs compounding.
Capilli M; Enrico F; Federici M; Comandone T
J Oncol Pharm Pract; 2022 Mar; 28(2):353-361. PubMed ID: 33567974
[TBL] [Abstract][Full Text] [Related]
18. Analysis of production time and capacity for manual and robotic compounding scenarios for parenteral hazardous drugs.
Geersing TH; Pourahmad DM; Lodewijk F; Franssen EJF; Knibbe CAJ; Crul M
Eur J Hosp Pharm; 2024 Jun; 31(4):352-357. PubMed ID: 36792350
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of gravimetric-based technology-assisted workflow for nonhazardous sterile product preparation.
Bucci TG; Hedrick TL; Roberts PA; Lin K; South MD; Willoughby IR; Eckel SF; Hess ET; Eberwein S; Amerine LB
Am J Health Syst Pharm; 2019 Jul; 76(14):1071-1077. PubMed ID: 31361879
[TBL] [Abstract][Full Text] [Related]
20. Impact of robotic antineoplastic preparation on safety, workflow, and costs.
Seger AC; Churchill WW; Keohane CA; Belisle CD; Wong ST; Sylvester KW; Chesnick MA; Burdick E; Wien MF; Cotugno MC; Bates DW; Rothschild JM
J Oncol Pract; 2012 Nov; 8(6):344-9, 1 p following 349. PubMed ID: 23598843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
